(Total Views: 529)
Posted On: 07/30/2025 8:01:37 AM
Post# of 87419
Re: mikeyt1818 #87286
Another 8K for IR-MED, closed yesterday at $0.0136
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On July 23, 2025, IR-Med, Inc. (the “Company”) entered into a second amendment to the employment agreement with Mr. Sharon Levkoviz, the Company’s Chief Financial Officer (the “Amendment”).
Pursuant to the terms of the Amendment, the monthly salary of Mr. Levkoviz will be reduced to NIS 7,500 and he will no longer be entitled to the benefit of a leased car or any related payment allowances starting August 1, 2025.
In addition, Mr. Levkoviz’s scope of employment will be reduced to 25% of his time as of August 1, 2025. All other terms related to Mr. Levkoviz’s overall compensation and equity-based awards remain unchanged.
https://www.otcmarkets.com/filing/html?id=186...nviQjlS-ch
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On July 23, 2025, IR-Med, Inc. (the “Company”) entered into a second amendment to the employment agreement with Mr. Sharon Levkoviz, the Company’s Chief Financial Officer (the “Amendment”).
Pursuant to the terms of the Amendment, the monthly salary of Mr. Levkoviz will be reduced to NIS 7,500 and he will no longer be entitled to the benefit of a leased car or any related payment allowances starting August 1, 2025.
In addition, Mr. Levkoviz’s scope of employment will be reduced to 25% of his time as of August 1, 2025. All other terms related to Mr. Levkoviz’s overall compensation and equity-based awards remain unchanged.
https://www.otcmarkets.com/filing/html?id=186...nviQjlS-ch
(3)
(0)
